Ascend Wellness Holdings Future Growth
Future criteria checks 0/6
Ascend Wellness Holdings is forecast to grow earnings and revenue by 83.1% and 3.2% per annum respectively while EPS is expected to grow by 43.6% per annum.
Key information
83.1%
Earnings growth rate
43.6%
EPS growth rate
Personal Products earnings growth | 25.5% |
Revenue growth rate | 3.2% |
Future return on equity | n/a |
Analyst coverage | Good |
Last updated | 20 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 585 | N/A | 41 | 53 | 2 |
12/31/2025 | 579 | -23 | 31 | 57 | 7 |
12/31/2024 | 566 | -81 | 27 | 40 | 7 |
9/30/2024 | 566 | -88 | 19 | 55 | N/A |
6/30/2024 | 565 | -71 | 29 | 80 | N/A |
3/31/2024 | 547 | -48 | 24 | 73 | N/A |
12/31/2023 | 519 | -48 | 35 | 75 | N/A |
9/30/2023 | 491 | -44 | -9 | 43 | N/A |
6/30/2023 | 461 | -50 | -57 | 13 | N/A |
3/31/2023 | 435 | -72 | -138 | -22 | N/A |
12/31/2022 | 406 | -81 | -164 | -38 | N/A |
9/30/2022 | 382 | -82 | -166 | -42 | N/A |
6/30/2022 | 365 | -79 | -144 | -50 | N/A |
3/31/2022 | 351 | -102 | -119 | -44 | N/A |
12/31/2021 | 332 | -123 | -130 | -42 | N/A |
9/30/2021 | 298 | -114 | -102 | -23 | N/A |
6/30/2021 | 245 | -106 | -87 | -18 | N/A |
3/31/2021 | 187 | -66 | -60 | -18 | N/A |
12/31/2020 | 144 | -25 | -33 | -6 | N/A |
12/31/2019 | 12 | -32 | -102 | -41 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: AAWH is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: AAWH is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: AAWH is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: AAWH's revenue (3.2% per year) is forecast to grow slower than the US market (8.9% per year).
High Growth Revenue: AAWH's revenue (3.2% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if AAWH's Return on Equity is forecast to be high in 3 years time